<DOC>
	<DOCNO>NCT00647153</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , immunoscintigraphy , use radiolabeled monoclonal antibody may help find diagnose colorectal cancer . PURPOSE : This clinical trial study well immunoscintigraphy use radiolabeled monoclonal antibody work find tumor cell patient colorectal cancer .</brief_summary>
	<brief_title>Immunoscintigraphy Using Radiolabeled Monoclonal Antibody Finding Tumor Cells Patients With Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine ability iodine I 123 anti-CEA recombinant diabody T84.66 localize colorectal cancer , determine quantitative radioimmunoscintigraphy patient colorectal cancer . Secondary - To evaluate clinical pharmacokinetics iodine I 123 anti-CEA recombinant diabody T84.66 clearance patient . - To characterize frequency titer human anti-chimeric response iodine I 123 anti-CEA recombinant diabody T84.66 patient . - To determine safety iodine I 123 anti-CEA recombinant diabody T84.66 patient . OUTLINE : Patients receive infusion iodine I 123 anti-CEA recombinant diabody T84.66 . Patients undergo planar image every 5 minute radiolabeled antibody infusion 3-6 hr , 12-24 hour , , indicate , 30-48 hour radiolabeled antibody infusion . Planar spot image head , chest , abdomen , pelvis whole body image ( anterior posterior ) take . Patients also undergo SPECT scan abdomen pelvis 12 24 hour radiolabeled antibody infusion . Blood sample collect pharmacokinetic analysis immediately radiolabeled antibody infusion 15 minute , 30 minute , 1 hour , 2 hour , 4 hour radiolabeled antibody infusion . Patients follow periodically 6 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm colorectal cancer Stage IIV disease PATIENT CHARACTERISTICS : Serum creatinine &lt; 2.0 mg/dL Total bilirubin &lt; 2.0 mg/dL Hemoglobin &gt; 9.0 g/dL cT84.66 antibody negative ( previously treat mouse chimeric immunoglobulin ) Not pregnant No condition , opinion investigator , would preclude study compliance No known allergy iodine No known history HIV , hepatitis B , hepatitis C PRIOR CONCURRENT THERAPY : No concurrent steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
</DOC>